Imaging biomarkers of NAFLD, NASH, and fibrosis

by Veeral Ajmera, Rohit Loomba
Published 2021-08-01

Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention

by Marialena Mouzaki, Rohit Loomba
Published 2019-06-01

The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?

by Erin Spengler, MD, Rohit Loomba, MD, MHSc
Published 2015-03-01

Is an Appreciation of Isomerism the Key to Unlocking the Mysteries of the Cardiac Findings in Heterotaxy?

by Robert H. Anderson, Diane E. Spicer, Rohit Loomba
Published 2018-02-01

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1

by Rohit Loomba, Oswald Quehenberger, Aaron Armando, Edward A. Dennis
Published 2015-01-01

Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

by Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
Published 2020-10-01

Alanine aminotransferase decreases with age: the Rancho Bernardo Study.

by Mamie H Dong, Ricki Bettencourt, Elizabeth Barrett-Connor, Rohit Loomba
Published 2010-12-01

Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study.

by Jeffrey K Lee, Ricki Bettencourt, David Brenner, Thuy-Anh Le, Elizabeth Barrett-Connor, Rohit Loomba
Published 2012-01-01

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

by Beth A Davison, Christopher Edwards, Rohit Loomba, Stephen A Harrison, Gad Cotter, Naim Alkhouri, Gary G Koch, Howard C Dittrich
Published 2021-07-01

Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease

by Suzanne R. Sharpton, Nobuharu Tamaki, Ricki Bettencourt, Egbert Madamba, Jinho Jung, Amy Liu, Cynthia Behling, Mark A. Valasek, Rohit Loomba
Published 2021-10-01

Practice patterns in NAFLD and NASH: real life differs from published guidelines

by Mary E. Rinella, Zurabi Lominadze, Rohit Loomba, Michael Charlton, Brent A. Neuschwander-Tetri, Stephen H. Caldwell, Kris Kowdley, Stephen A. Harrison
Published 2016-01-01

Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls

by Niraj S. Patel, Michael R. Peterson, Grace Y. Lin, Ariel Feldstein, Bernd Schnabl, Ricki Bettencourt, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba
Published 2013-01-01

Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut

by Idania Marrero, Idania Marrero, Igor Maricic, Igor Maricic, Ariel E. Feldstein, Rohit Loomba, Bernd Schnabl, Jesus Rivera-Nieves, Lars Eckmann, Vipin Kumar, Vipin Kumar
Published 2018-09-01

Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis

by Cyrielle Caussy, Jen-Chieh Chuang, Andrew Billin, Tao Hu, Ya Wang, G. Mani Subramanian, C. Stephen Djedjos, Robert P. Myers, Edward A. Dennis, Rohit Loomba
Published 2020-05-01

Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis

by Janki Patel, Ricki Bettencourt, Jeffrey Cui, Joanie Salotti, Jonathan Hooker, Archana Bhatt, Carolyn Hernandez, Phirum Nguyen, Hamed Aryafar, Mark Valasek, William Haufe, Catherine Hooker, Lisa Richards, Claude B. Sirlin, Rohit Loomba
Published 2016-09-01

Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder

by Bei Gao, Atoosa Emami, Rongrong Zhou, Sonja Lang, Yi Duan, Yi Duan, Yanhan Wang, Yanhan Wang, Lu Jiang, Lu Jiang, Rohit Loomba, David A. Brenner, Peter Stärkel, Bernd Schnabl, Bernd Schnabl
Published 2020-04-01

Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial

by Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba
Published 2016-03-01

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

by Cyrielle Caussy, Anupriya Tripathi, Greg Humphrey, Shirin Bassirian, Seema Singh, Claire Faulkner, Ricki Bettencourt, Emily Rizo, Lisa Richards, Zhenjiang Z. Xu, Michael R. Downes, Ronald M. Evans, David A. Brenner, Claude B. Sirlin, Rob Knight, Rohit Loomba
Published 2019-03-01

Links between gut microbiome composition and fatty liver disease in a large population sample

by Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, Aki S. Havulinna, Guillaume Méric, Yang Liu, Rohit Loomba, Yoshiki Vázquez-Baeza, Anupriya Tripathi, Liisa M. Valsta, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen
Published 2021-01-01

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study

by A. Sidney Barritt, Stephanie Watkins, Norman Gitlin, Samuel Klein, Anna S. Lok, Rohit Loomba, Cheryl Schoen, K. Rajender Reddy, Huy Ngoc Trinh, Andrea R. Mospan, Miriam B. Vos, L. Michael Weiss, Kenneth Cusi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal
Published 2021-06-01